DOI QR코드

DOI QR Code

Short and Efficient Synthesis of Licochalcone B and D Through Acid-Mediated Claisen-Schmidt Condensation

  • Wang, Zengtao (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Liu, Zhiguo (School of Pharmacy, Wenzhou Medical College) ;
  • Cao, Yongkai (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Paudel, Suresh (College of Pharmacy and Research Institute of Drug Development, Chonnam National University) ;
  • Yoon, Goo (College of Pharmacy and Natural Medicine Research Institute, Mokpo National University) ;
  • Cheon, Seung Hoon (College of Pharmacy and Research Institute of Drug Development, Chonnam National University)
  • 투고 : 2013.09.06
  • 심사 : 2013.09.25
  • 발행 : 2013.12.20

초록

키워드

Experimental Section

General Experiments. All solvents were purchased from OCI (Seoul, Korea). Reagents were obtained from Alfa Aesar or Aldrich and were used without further purification. Silica gel plates (F254; Merck, Germany) and silica gel 60 (70-230 mesh; Merck) were used for analytical and column chromatography, respectively. Melting points were determined in capillary tubes using a capillary melting point apparatus and are not corrected. Nuclear magnetic resonance (NMR) spectra 300 MHz for 1H-NMR, 75 MHz for 13C-NMR were recorded on a Varian Unity Plus 300 spectrometer, which were performed using CDCl3 or dimethylsulfoxide (DMSO)- d6 as a solvent at room temperature. Chemical shift (δ) was expressed in ppm relative to tetramethylsilane used as an internal standard, coupling constant (J) values are estimated in hertz (Hz) and spin multiples are given as s (singlet), d (doublet), dd (double doublets), m (multiplet), and br (broad). The mass spectra (MS) were acquired in positive mode over 100:600 m/z range using a Varian 1200L triple quadrupole mass spectrometer equipped with electrospray ionization (ESI) source. Compounds were visualized by ultraviolet light.

Compound 4.To a suspended solution of 2,3,4-trihydroxybenzaldehyde (1.2 g, 8 mmol) in dichloromethane (10 mL) was added N,N-diisopropylethylamine (2.8 mL, 17 mmol), and stirred for 15 min at 0 ℃. Methoxymethyl chloride (1.3 mL, 17 mmol) was then added drop-wise. The mixture was stirred at 0 ℃ for 15 min then at room temperature for 1 h. The reaction mixture was poured into water and extracted with chloroform. The organic layer was concentrated under reduced pressure, and the residue was subjected to silica gel column chromatography (hexane-EtOAc= 10:1) to afford 2-hydroxy-3,4-bis(methoxymethoxy)benzaldehyde (1.37 g, 71%) as a white solid. mp 55-56 ℃. LCEIMS: m/z = 241 [M-H]−. 1H-NMR (CDCl3)δ 11.30 (1H, s), 9.75 (1H, s), 7.28 (1H, d, J = 8.7 Hz), 6.82 (1H, d, J= 8.7 Hz), 5.30 (2H, s), 5.20 (2H, s), 3.64 (3H, s), 3.51 (3H, s). 13C-NMR (CDCl3) δ 195.05, 157.07, 156.07, 133.23, 130.15, 116.83, 107.05, 97.91, 94.52, 57.19, 56.49.

Compound 5. To a stirred solution of 4 (1.37 g, 5.7 mmol) in DMF (14 mL) was added to a suspension of NaH (344 mg, 60% in oil, 8.6 mmol) in DMF (16 mL) under cooling with ice-water. After being stirred at the same temperature for 30 min, followed by CH3I (0.54 mL, 8.6 mmol) at room temperature, and the mixture was stirred at same temperature overnight, which was quenched with an aqueous NH4Cl solution (saturated), then extracted with ethyl acetate (EtOAc) and the combined organic layer was washed with water and brine, dried over MgSO4, filtered and concentrated under reduced pressure to give a crude oil, which was purified by silica gel chromatography (hexane-EtOAc = 10:1) to give a colorless oil liquid (1.38 g, 95%). 1H-NMR (300 MHz, CDCl3) δ 10.25 (1H, d, J = 0.6 Hz), 7.60 (1H, d, J = 9.0 Hz), 7.01 (1H, dd, J = 9.0, 0.9 Hz), 5.28 (2H, s), 5.17 (2H, s), 4.01 (3H, s), 3.63 (3H, s), 3.52 (3H, s). 13C-NMR (CDCl3) δ 188.26, 157.08, 156.49, 138.94, 124.05, 123.93, 110.79, 98.36, 94.41, 62.29, 56.97, 56.17.

Compound 6b.

Method A: A solution of 4-hydroxyacetophenone (6a) (5 g, 36.8 mmol) in dry THF (50 mL) was added to a slurry of BaO (3 eq) and A12O3 (3 eq, basic or neutral Type T or E for thin layer chromatography; Merck) in dry ether-hexane (55 mL, 1:1). After 2 h, the solvent was evaporated and 2 eq of prenyl bromide in CH2Cl2 (90 mL) was added. After 4 days the solid was filtered off and washed with 1% HOAc- EtOAc. The combined organic layers were evaporated and compound 6b was obtained as a white-pale yellow crystalline solid (2.63 g, 35%) over silica gel column using mixtures of hexanes and EtOAc (10:1 to 7:1) as eluent.

Method B: Compound 6a (25 g) in 150 mL dioxane was added to a stirred fresh solution of 2-methyl-3-buten-2-ol (20 g) and 12.5 mL BF3·OEt2 in 100 mL dioxane, and stirring was continued for 5 h at room temperature. Ether (250 mL) was added and the resulting solution was extracted with water (3 × 500 mL). The remaining organic layer was dried over MgSO4 before evaporation to dryness. The crystalline residue was extracted with hexane (5 × 50 mL), which dissolved the reaction products and left behind most unchanged starting material. After evaporation of the solvent in vacuo the crude residue was purified by flash chromatography (hexane:EtOAc = 10:1) to give 6b (4.65 g, 31%) based on recovered compound 6a (15 g, 60%).

Method C: 4-Hydroxyacetophenone (6a, 2 g, 14.7 mmol) was dissolved in aqueous potassium hydroxide (0.82 g in 8 mL water, 14.7 mmol) solution at room temperature. To this solution, 3,3-dimethylallyl bromide (3.5 g, 23.7 mmol) and aqueous potassium hydroxide (0.82 g in 8 mL water, 14.7 mmol) were added simultaneously, in portion-wise over 1 h and the reaction mixture was stirred for 48 h at around 45 ℃. After completion of the reaction (monitored by TLC), the reaction mass was basified further with potassium hydroxide (0.82 g in 8 mL water, 14.7 mmol) and extracted with toluene (2 × 10 mL) to remove O-prenylated product. The aqueous layer was then acidified with acetic acid at ice water bath temperature to pH 5.0 and was extracted with ethyl acetate (3 × 10 mL). The organic layer was dried over anhydrous MgSO4 and evaporated under reduced pressure to obtain the product (1.82 g). The crude product obtained was column chromatographed on silica gel (hexane-EtOAc = 10:1) to afford the pure product (6b, 1.41 g, 47%).

Compound 6b: mp 81-83 ℃. LC-EIMS: m/z= 203 [MH]−. 1H-NMR (CDCl3) δ 7.79(1H, d, J = 2.1 Hz), 7.75 (1H, dd, J = 8.4, 2.1 Hz), 7.43 (1H, s, br), 6.91 (1H, d, J = 8.4 Hz), 5.30-5.36 (1H, m), 3.40 (2H, d, J = 4.2 Hz), 2.57 (3H, s), 1.76 (6H, s). 13C-NMR (CDCl3) δ 198.68, 159.73, 134.17, 130.76, 129.36, 128.81, 127.86, 121.29, 115.17, 28.80, 26.18, 25.69, 17.78.

Licochalcone B and D (1 and 2). Compound 5 (1.0 eq) and intermediate 6a or 6b (1.1 eq) were dissolved in anhydrous EtOH, cooled by ice-water bath, then anhydrous 2.0 M HCl-EtOH (6 eq) was added slowly to the stirred solution. The mixture was continuously stirred for 15-20 h at 0 °C. When the starting martial 6a or 6b disappeared (monitored by TLC), then the mixture was kept stirring at room temperature for 8-12 h. HCl and EtOH solvent were removed under reduced pressure, and the residue was then extracted with EtOAc, washed with H2O, saturated aqueous NaHCO3 solution, and H2O. After the extracted organic layer was dried over MgSO4, and filtered, the solvent was removed under reduced pressure. Licochalcone B (1) or licochalcone D (2) was obtained as a yellow solid after silica gel column chromatography using mixture of chloroformmethanol- acetic acid (200:4:1) as an eluent.

Licochalcone B (1, 62%): mp 196-198 ℃. LC-EIMS: m/z = 285 [M-H]−. 1H-NMR (DMSO-d6) δ 8.00 (2H, d, J = 8.7 Hz), 7.84 (1H, d, J = 15.9 Hz), 7.66 (1H, d, J = 15.9 Hz), 7.33 (1H, d, J = 8.7 Hz), 6.88 (2H, d, J = 8.7 Hz), 6.62 (1H, d, J = 8.4 Hz), 3.77 (3H, s). 13C-NMR (DMSO-d6) δ 187.27, 172.53, 162.01, 149.90, 148.63, 138.47, 138.28, 130.92, 129.56, 119.48, 119.02, 118.53, 115.41, 111.82, 60.79.

Licochalcone D (2, 57%): mp 112-114 ℃. LC-EIMS: m/z= 353 [M-H]−. 1H-NMR (CDCl3) δ 7.92 (1H, d, J = 15.6 Hz), 7.87 (1H, s), 7.85 (1H, d, J = 5.1 Hz), 7.54 (1H, d, J = 15.6 Hz), 7.20 (1H, d, J = 9.0 Hz), 6.89 (1H, d, J = 9.0 Hz), 6.78 (1H, d, J = 8.7 Hz), 5.65 (3H, br), 5.32-5.37 (1H, m), 3.87 (3H, s), 3.44 (2H, d, J = 7.5 Hz), 1.81 (3H, s), 1.80 (3H, s). 13CNMR (CDCl3) δ 189.34, 158.91, 147.24, 146.95, 138.73, 136.60, 135.70, 131.22, 131.09, 128.97, 127.08, 121.04, 120.74, 120.35, 115.65, 111.88, 62.27, 29.82, 25.82, 17.97.

참고문헌

  1. Saitoh, T.; Shibata, S. Tetrahedron Lett. 1975, 16, 4461. https://doi.org/10.1016/S0040-4039(00)91092-X
  2. Kajiyama, K.; Demizu, S.; Hiraga, Y.; Kinoshita, K.; Koyama, K.; Takahashi, K.; Tamura, Y.; Okada, K.; Kinoshita, T. Phytochemistry 1992, 31, 3229. https://doi.org/10.1016/0031-9422(92)83481-D
  3. Yoon, G.; Jung, Y. D.; Cheon, S. H. Chem. Pharm. Bull. 2005, 53, 694. https://doi.org/10.1248/cpb.53.694
  4. Park, E. J.; Park, H. R.; Lee, J. S.; Kim, J. W. Planta. Med. 1998, 64, 464. https://doi.org/10.1055/s-2006-957485
  5. Yoon, G.; Kang, B. Y.; Cheon, S. H. Arch. Pharm. Res. 2007, 30, 313. https://doi.org/10.1007/BF02977611
  6. Furusawa, J.-I.; Funakoshi-Tago, M.; Mashino, T.; Tago, K.; Inoue, H.; Sonoda, Y.; Kasahara, T. Int. Immunopharmacol. 2009, 9, 499. https://doi.org/10.1016/j.intimp.2009.01.031
  7. Tanifuji, S.; Aizu-Yokota, E.; Funakoshi-Tago, M.; Sonoda, Y.; Inoue, H.; Kasahara, T. Int. Immunopharmacol. 2010, 10, 769. https://doi.org/10.1016/j.intimp.2010.04.007
  8. Li, Y.-J.; Chen, J.; Li, Y.; Li, Q.; Zheng, Y.-F.; Fu, Y.; Li, P. J. Chromatogr. A 2011, 1218, 8181. https://doi.org/10.1016/j.chroma.2011.09.030
  9. Kim, S.-J.; Jun, J.-G. Bull. Korean Chem. Soc. 2013, 34, 54. https://doi.org/10.5012/bkcs.2013.34.1.54
  10. Saito, S.; Kawabata, J. Tetrahedron 2005, 61, 8101. https://doi.org/10.1016/j.tet.2005.06.040
  11. Liu, Z.; Lee, W.; Kim, S.-N.; Yoon, G.; Cheon, S. H. Bioorg. Med. Chem. Lett. 2011, 21, 3755. https://doi.org/10.1016/j.bmcl.2011.04.057
  12. Helesbeux, J.-J.; Duval, O.; Ruilet, D.; Seraphin, D.; Rondeau, D. Tetrahedron 2003, 59, 5091. https://doi.org/10.1016/S0040-4020(03)00733-6
  13. Rao, G. V.; Swamy, B. N.; Chandregowda, V.; Reddy, G. C. Eur. J. Med. Chem. 2009, 44, 2239. https://doi.org/10.1016/j.ejmech.2008.05.032
  14. Kromann, H.; Larsen, M.; Boesen, T.; Schonning, K.; Nielsen, S. F. Eur. J. Med. Chem. 2004, 39, 993. https://doi.org/10.1016/j.ejmech.2004.07.004

피인용 문헌

  1. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways vol.48, pp.4, 2016, https://doi.org/10.3892/ijo.2016.3365
  2. Natural Compound Licochalcone B Induced Extrinsic and Intrinsic Apoptosis in Human Skin Melanoma (A375) and Squamous Cell Carcinoma (A431) Cells vol.31, pp.12, 2017, https://doi.org/10.1002/ptr.5928
  3. Licochalcone D directly targets JAK2 to induced apoptosis in human oral squamous cell carcinoma vol.234, pp.2, 2018, https://doi.org/10.1002/jcp.27050
  4. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma vol.52, pp.None, 2013, https://doi.org/10.1016/j.phymed.2018.09.180
  5. Microbial Transformation of Licochalcones vol.25, pp.1, 2013, https://doi.org/10.3390/molecules25010060
  6. Licochalcone D Induces ROS-Dependent Apoptosis in Gefitinib-Sensitive or Resistant Lung Cancer Cells by Targeting EGFR and MET vol.10, pp.2, 2013, https://doi.org/10.3390/biom10020297
  7. Microbial Transformation of Broussochalcones A and B by Aspergillus niger vol.84, pp.3, 2013, https://doi.org/10.1021/acs.jnatprod.0c01102